CUSIP: G10830100 | Healthcare · Biotechnology | Micro Cap | 160 institutional holders
5%+ stakes reported outside the quarterly cycle. A 13D is due within five business days of the event below, so these figures lead the holders table until the filer's next 13F catches up to them.
| Holder | Shares | % of Class | Change | Event Date | vs 13F |
|---|---|---|---|---|---|
| 13G/AXiangmin Cui with Decheng Capital China Life Sciences USD Fund II, L.P., Decheng Capital Management II (Cayman), LLC, Decheng Capital Management III (Cayman), LLC, +3 more | 3,065,702 | 7.5% | New 5%+ stake | Sep 30, 2026 | No 13F filer matched |
| 13G/ALinqing Jia with Ever Regal Group Ltd, Rosy Time Holdings Limited, Fairy Eagle Investments Limited | 5,293,444 | 12.9% | New 5%+ stake | Jun 30, 2026 | No 13F filer matched |
| Style | Turnover | Location | Filed | ||||
|---|---|---|---|---|---|---|---|
| 10,000 | $7.7K | 0.0% | Growth | Low | Lexington, KY | 2026-11-05 | |
| 1,500 | $1.2K | 0.0% | Agg Growth | Very Low | Northbrook, IL | 2026-10-21 | |
| 929 | $715 | 0.0% | Core | Very High | Chicago, IL | 2026-11-04 | |
| 76 | $59 | 0.0% | Agg Growth | Low | Tokyo, Mexico | 2026-10-22 | |
| 1 | $1 | 0.0% | Growth | Very High | Hong Kong, South Korea | 2026-10-29 |